	Alzheimer’s disease
Vesicular glutamate transporter
Glutamine transporter
β-Amyloid peptide (25-35)
Cell culture
	cells
cultures
SAT
neuronal SAT
neurons
transporter immunoreactivities
linear mixed model
antiVGLUT 2 1
immunoreactivities
glial glutamate transporters
MAP
effect
quantitative analysis
similar
neuronal marker MAP 2
transporter proteins
rat cerebral cortex
amino acids
Fig
rats
toxic
VGLUT
statistical tests
analysis
peptide
glutamate
transporters
normal morphology
significant
vesicular glutamate transporters
SN 1
double
level
incubated

